Platelet-Derived Endothelial Cell Growth Factor Expression in Tumor and Stroma Cells of Bladder Transitional Cell Carcinoma

李纲,张元芳,丁强,温端改,严春寅

DOI: https://doi.org/10.3969/j.issn.1009-881x.2003.04.001

2003-01-01

Abstract:Objective To analyze the expression difference of platelete-derived endothelial cell growth factor (PD-ECGF) between tumor cells and stroma cells in bladder transitional cell carcinoma(TCC) and its clinical implication. Methods Immunohistochemical staining with anti-PD-ECGF monoclonal antibody 1C6-203 was used to analyze the PD-ECGF expression of tumor and stroma cells in 55 cases of bladder TCC and 8 cases of nomal bladder mucosa. Results Normal bladder mucosa showed negative anti-PD-ECGF immuno-staining in both epithelial and stroma cells. Tumor cells expressed positive staining of PD-ECGF in 25/55(45.5%) cases of bladder TCC, Positive tumor cell PD-ECGF expression was found in 2/7(28.6%) cases of G 1,in 9/25(36.0%) cases of G 2 and in 14/23(60.9%) cases of G 3 tumors ( x 2=3.91, P 0.05);and was found in 3/18(16.7%) cases of Ta,in 5/14(35.7%) cases of T 1 and in 17/23(73.9%) cases of T 2～4 tumors ( x 2=14.0, P 0.001). Tumor stroma cells displayed positive PD-ECGF staining in 37/55 (67.3.%) cases of bladder TCC. Positive stroma cell PD-ECGF staining was found in 3/7(42.9%) cases of G 1,in 14/25 (56.0%) cases of G 2 and in 20/23(87.0%) cases of G 3 tumors ( x 2=7.39, P 0.05);and was found in 5/18(27.8%) cases of Ta,in 12/14(85.7%) cases of T 1 and in 20/23(87.0%) cases of T 2～4 tumors ( x 2=30.2, P 0.001). Conclusion Positive expression of PD-ECGF in both tumor and stroma cells might play an important role in the malignant progression of bladder TCC and may be used as a predicator of tumor dediferentiation and invasiveness in bladder cancer.